Podcast

The Endocrine Society's Latest Osteoporosis Guideline

05/18/2022

Clifford Rosen, MD, chair of the Endocrine Society's 2019 clinical practice guideline for the pharmacological management of osteoporosis in postmenopausal women, reviews key points of the new guideline.

Clifford Rosen, MD, is an endocrinologist, bone biologist, director of Clinical and Translational Research and senior scientist at Maine Medical Center’s Research Institute, and professor of medicine at Tufts University School of Medicine. He is also a member of the US Food and Drug Administration's Advisory Panel on Endocrinologic and Metabolic Drugs and associate editor of the New England Journal of Medicine.

*Note: A formal amendment to the 2019 guideline was recently issued regarding romosozumab. Click here to read about the update.

Additional Resources:
Eastell R, Rosen CJ, Black DM, Cheung AM, Murad MH, Shoback D. Pharmacological management of osteoporosis in postmenopausal women: an Endocrine Society* clinical practice guideline. J Clin Endocrinol Metab. 2019;104(5):1595-1622. https://doi.org/10.1210/jc.2019-00221

 

Related Content

Neurology
Neurology
Eleanor Mackey, PhD, on Bariatric Surgery May Normalize Brain Function, Too
12/06/2017
<p>Dr Eleanor Mackey, from Children's National Health System, discusses her latest research about the effect of bariatric surgery on changes in the brain in adolescents.</p>
12/06/2017
Preventive Medicine
Preventive Medicine
Congenital Syphilis and Penicillin as Prevention
02/08/2022
She discusses her virtual session at CROI 2020, during which she talked about global trends in congenital syphilis, prevention of mother-to-child transmission, and why every pregnant woman with syphilis...
02/08/2022
Traumatic Brain Injury
Traumatic Brain Injury
Paul Pasquina, MD, on Brain Injury in Military Personnel
07/28/2019
This podcast discusses the perspective of the DoD regarding concussion and other TBIs in military personnel.
07/28/2019
Heart Failure
Heart Failure
Thomas Seck, MD, on Expanding Empagliflozin Use for Heart Failure
04/04/2018
<p>Dr Thomas Seck from Boehringer Ingelheim Pharmaceuticals discusses the EMPERIAL trials, which aim to expand the use of empagliflozin for heart failure.</p>
04/04/2018
Pneumonia
Pneumonia
Unmet Needs in Treatment of CABP
10/17/2022
In this podcast, Frank LoVecchio, MD, speaks about the unmet needs in the treatment of community-acquired bacterial pneumonia, and potential alternatives to the standard treatment regimen. This podcast is...
10/17/2022